Did you know?

ChinaBio^® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

Free Report

State of China Life Science 2022

Free Content

Week in Review

In My Opinion

Free Articles

Subscriber Content

Ping An Signs Strategic Oncology Partnership MOU with Varian

publication date: Jan 11, 2018

Ping An Health Technology has signed a MOU with Varian, a US maker of radiology machines that treat and manage cancer, to form a strategic partnership for expanding cancer care access in China. The two companies plan to investigate the use of artificial intelligence, cloud computing and big data technologies with the goal of delivering high quality, cost-effective cancer care to more people in China at centers that are close to their homes. Ping An Healthcare is the medical arm of China's Ping An Insurance. More details....

Stock Symbols: (NYSE: VAR) (SHA: 601318; HK: 2318)

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Click here to join.